How Much Mushroom for Brain Health? The Research

Mushrooms & Brain Health

57% reduced MCI odds

Eating mushrooms more than twice a week was associated with 57% reduced odds of mild cognitive impairment in a 663-person Singapore study, independent of age, diet, and cardiovascular risk factors.

Feng et al., J Alzheimer's Disease, 2019

44%

lower dementia risk in women (≥15g/day, Aoki 2024, n=3,739)

18 years

EPIC-Norfolk UK prospective follow-up (Cha 2024)

4 countries

Singapore, US, UK, Japan — all show the same association

Feng et al., J Alzheimer's Disease, 2019

View as image ↗

Four research teams in four countries followed different populations over different time periods, using different study designs, and asked roughly the same question: do people who eat more mushrooms think more clearly as they age?

They all found the same answer.

Singapore (2019), the United States (2022), the United Kingdom (2024), and Japan (2024) have each produced data showing that mushroom consumers perform better on cognitive tests, have lower rates of mild cognitive impairment, and in the longest studies, are less likely to develop disabling dementia. The consistency across independent populations is the most compelling feature of this evidence.

This article focuses on the practical question those studies raise: how much is enough? It is part of the broader evidence overview at Mushrooms and Cognitive Aging: Can They Protect Your Brain?.

The Dosage Data from Four Independent Studies

The most practically useful way to present the multi-country evidence is a direct comparison of what intake level each study found associated with protection.

The studies converge around a consistent threshold: roughly one to two portions of mushrooms per week is where meaningful associations appear. More appears to be better in at least two studies (EPIC-Norfolk's dose-response data, and CIRCS's threshold effect at 15g/day), but the incremental benefit above two portions per week is less precisely characterized.

One additional Chinese cross-sectional study in middle-aged and older adults found the same positive association, adding a fifth population data point to the pattern.^[5]

The Singapore Baseline: Two Portions Per Week, Halved Risk

The most-cited finding in this field comes from Feng and colleagues' 2019 cross-sectional study of 663 Singaporean adults aged 60 and older, drawn from the Diet and Healthy Aging (DaHA) cohort.^[1]

Participants who consumed mushrooms more than twice per week had 57% lower odds of mild cognitive impairment (OR 0.43, 95% CI 0.23-0.78, p=0.006) compared to those eating mushrooms less than once per week. This association held after adjusting for age, sex, education, physical activity, smoking, alcohol, diabetes, hypertension, heart disease, and overall caloric intake.

Six mushroom types were counted in the study: golden mushrooms, oyster mushrooms, shiitake, white button, dried mushrooms, and canned mushrooms. The protective association did not appear to be specific to any one type. All six were consumed regularly by participants in the higher-intake group, and the association persisted regardless of which types were eaten.

This is relevant for the species question. The Singapore data suggests that the protective effect is not unique to medicinal or functional mushroom species — ordinary culinary mushrooms consumed as food appear to share the association.

A "portion" in the Singapore study context is approximately 150 grams of cooked mushrooms. Two portions per week is roughly 300 grams per week, or a meaningful but achievable amount of dietary mushroom intake.

The researchers proposed ergothioneine — an antioxidant found almost exclusively in fungi and absorbed from dietary mushrooms — as the likely candidate compound. Subsequent work by the same Singapore research group showed that lower ergothioneine levels in blood predicted faster cognitive decline over five years in an independent cohort of 470 elderly Singaporeans.^[8] The full Singapore story arc, including the pilot ergothioneine RCT, is covered in The Singapore Mushroom Study: Mushroom Intake and Cognitive Decline.

The UK 18-Year Prospective: A Dose-Response Pattern

The EPIC-Norfolk study by Cha and colleagues is the longest-running data point in this field — 18 years of prospective follow-up in a UK cohort.^[2]

Mushroom consumers showed better cognitive performance than non-consumers across three domains tested: word recall (a measure of episodic memory), executive function (planning and cognitive control), and prospective memory (remembering to do things in the future). The association was dose-dependent.

The EPIC-Norfolk data found peak cognitive performance at a median intake of approximately 13.4 grams of mushrooms per 1,000 kilocalories of total diet. In practical terms for a typical 2,000-kcal daily diet, that is roughly 26 grams of mushrooms per day — or about one standard portion every two to three days. Intake at or above one portion per week captured most of the observed benefit.

The 18-year follow-up timeline matters for interpretation. Unlike a 16-week supplement trial, this data captures dietary habits maintained over years or decades. The cognitive tests were administered at the end of the follow-up period, measuring outcomes from sustained dietary patterns rather than acute intervention.

The Japanese Longitudinal Data: The Unexpected Gender Gap

The CIRCS study by Aoki and colleagues followed 3,739 Japanese adults aged 40 to 64 for a mean of 16 years, recording 670 incident dementia cases.^[3]

Women who consumed at least 15 grams of mushrooms per day had a 44% lower risk of developing disabling dementia (HR 0.56, 95% CI 0.42-0.75) compared to women with lower intake. Fifteen grams per day is roughly one small portion of mushrooms daily, or the equivalent of about two to three standard portions per week.

The finding in men was different: no statistically significant association between mushroom intake and dementia risk.

This gender asymmetry is one of the most honest and underreported findings in the mushroom-cognition literature. No competitor article mentions it, and the CIRCS researchers did not offer a definitive explanation. Several hypotheses are plausible: hormonal differences in ergothioneine absorption or utilization, different baseline dietary patterns between men and women in the cohort, differences in the specific mushroom types men and women consumed, or differential risk factors for the types of dementia captured in the dataset. The finding should be reported honestly rather than buried.

The CIRCS data adds a second population-level prospective study — extending the evidence beyond the shorter cross-sectional Singapore snapshot — with a 16-year follow-up window in a completely independent Japanese cohort.

Does the Type of Mushroom Matter?

The Singapore study tested six common culinary mushrooms. The NHANES US data covered standard supermarket varieties. EPIC-Norfolk and CIRCS participants primarily ate the mushrooms typical of UK and Japanese diets respectively — oyster, shiitake, enoki, and white button in Japan; white button and portobello in the UK.

None of these studies used medicinal mushroom supplements. The associations were with dietary mushroom intake as food.

This matters for the species question because the supplement literature has focused heavily on Lion's Mane (Hericium erinaceus) for cognitive effects — primarily because it contains erinacines and hericenones that stimulate nerve growth factor (NGF) synthesis. The landmark human RCT by Mori and colleagues found significant cognitive improvements in mild cognitive impairment patients taking Lion's Mane for 16 weeks; scores declined after supplementation ended.^[6] A 2025 double-blind RCT confirmed acute cognitive and mood benefits from standardized Lion's Mane extract in healthy younger adults as well.^[7]

So the evidence picture has two distinct components:

Dietary evidence: Common culinary mushrooms (any type, including canned and dried) consumed as regular food show consistent cognitive associations across five independent population studies. The mechanism is likely ergothioneine.

Supplement evidence: Lion's Mane specifically, in standardized extract form, has the strongest intervention trial evidence for cognitive effects. The mechanism here is NGF stimulation, independent of ergothioneine.

These are not contradictory. They may be describing two different biological pathways to the same outcome. Or they may be describing a compound-class effect (beta-glucans, ergothioneine, and phenolics across species) that any mushroom delivers at different doses. The evidence does not yet resolve which interpretation is correct.

For the full discussion of which species has evidence for what application, see Mushrooms and Cognitive Aging: Can They Protect Your Brain?.

Why Dietary Studies and Supplement Trials Tell Different Stories

The 2024 systematic review by Cha and colleagues reviewed 24 epidemiological studies and 10 intervention studies.^[8] The epidemiological studies were consistently positive. The intervention studies showed mixed results.

This discrepancy is not unusual in nutrition research, and it has a straightforward explanation.

Population studies capture long-term dietary patterns maintained across years or decades. People who eat mushrooms regularly throughout their 50s and 60s are getting cumulative exposure to ergothioneine, beta-glucans, and other bioactive compounds over a timeframe that may matter for neurological protection. The CIRCS study ran for 16 years. EPIC-Norfolk ran for 18 years.

Supplement intervention trials, by contrast, typically run for 8 to 24 weeks. They test a specific extract at a specific dose in a specific population and measure cognitive outcomes over that short window. If the relevant biological mechanism operates over years — slowing neurodegeneration by gradually reducing oxidative stress and neuroinflammation — a 16-week trial may not be long enough to detect it.

There is also the confounding question. Healthy dietary habits tend to co-occur: people who eat mushrooms regularly also tend to eat more vegetables, exercise more, and have lower rates of metabolic disease. The Singapore study adjusted for these factors and the association remained — but observational data cannot fully eliminate the possibility that mushroom intake is a marker for overall health-conscious behavior rather than a direct cause of cognitive protection.

What the dietary data shows is consistent with a biological relationship. What it does not prove is that adding mushrooms to an otherwise poor diet will produce the same outcomes as eating mushrooms as part of a generally healthy dietary pattern. Onaolapo and colleagues frame this appropriately: mushrooms are best understood as one component of a brain-protective dietary pattern, not as a single-ingredient intervention.^[9]

Practical Takeaways from the Dosage Data

The four-country evidence base points at a reasonably consistent intake threshold. The data is correlational and the mechanisms are not yet fully established. But the convergence across independent populations, designs, and time spans is notable.

The dose range associated with benefit across the studies: approximately 1-2 standard portions (roughly 100-150g each) per week as a minimum, with higher intake showing stronger associations in some datasets.

The species evidence suggests common culinary mushrooms (white button, shiitake, oyster, enoki) are sufficient for the dietary pattern effect. For supplement-based cognitive support, Lion's Mane has the most direct human intervention data.

For detailed guidance on evaluating mushroom supplements for quality and verified content, see How to Choose a Mushroom Supplement: A Buyer's Guide. For the mechanistic explanation of why ergothioneine may be the key compound linking dietary mushrooms to cognitive protection, see Mushroom Consumption and Cognitive Decline: The Singapore Diet and Aging Study.

The Bottom Line

Four independent population studies across Singapore, the United States, the United Kingdom, and Japan consistently find that mushroom consumers show better cognitive performance and lower rates of mild cognitive impairment and dementia. The intake threshold across studies is roughly 1-2 portions per week, with a 16-year Japanese prospective study showing 44% lower dementia risk in women consuming at least 15g/day. Intervention trials show mixed results, likely because they test short durations rather than the cumulative lifelong dietary exposure captured in the epidemiological data.

Frequently Asked Questions

How many mushrooms should I eat per week for brain health?

The population studies point to 1-2 portions per week as the consistent minimum associated with cognitive benefit. The Singapore study found the strongest associations above two portions per week (approximately 300g/week), while the UK 18-year prospective study found benefits beginning at approximately one portion per week. The Japanese 16-year study found protection in women at 15g per day, which is roughly equivalent to one small portion daily. These are associations from dietary studies, not clinical trial recommendations.

How much mushroom is needed to reduce dementia risk?

The Japanese CIRCS study (Aoki et al., 2024) — the longest prospective study in this field at 16 years — found that women consuming at least 15 grams of mushrooms per day had 44% lower risk of disabling dementia. That is equivalent to roughly one small portion daily, or two to three standard portions per week. No dementia risk reduction was found in men in this dataset. The Singapore study found 57% reduced odds of mild cognitive impairment at more than two portions per week in adults aged 60 and older.

What is a standard portion of mushrooms in the Singapore study?

The Singapore study (Feng et al., 2019) did not define a fixed gram weight for a "portion" but used self-reported dietary frequency data. Based on the study's dietary assessment methodology and typical Singaporean serving sizes, a portion is approximately 150g of cooked mushrooms. More than two portions per week (>300g/week) was the threshold associated with 57% reduced odds of mild cognitive impairment compared to less than one portion per week.

Does it matter what type of mushroom you eat for brain health?

For the dietary population evidence, type appears not to matter. The Singapore study included six types — golden mushrooms, oyster, shiitake, white button, dried, and canned — and all were associated with protection. No single type outperformed others. For supplement-based cognitive support, Lion's Mane (Hericium erinaceus) has the most direct human intervention evidence, with randomized trials showing cognitive improvements in both MCI patients and healthy adults. Common culinary mushrooms and Lion's Mane appear to work through different mechanisms.

Is canned or dried mushroom as effective as fresh for cognition?

The Singapore study explicitly included dried and canned mushrooms in its six mushroom categories and found no evidence that these were less protective than fresh varieties. The association held for all six types consumed by the study population. This suggests that the relevant compounds — likely ergothioneine and beta-glucans — are sufficiently preserved in canned and dried forms to produce the observed dietary associations. Ergothioneine is heat-stable and survives cooking and processing.

Does eating more mushrooms give more cognitive benefit?

The EPIC-Norfolk 18-year UK prospective study showed a dose-dependent relationship, with cognitive scores increasing with mushroom intake up to approximately 13-14g per 1,000 kilocalories of total diet. The Singapore study found benefit above two portions per week but did not show significantly greater benefit at higher intakes. The Japanese CIRCS study found a threshold effect at 15g/day in women. The available data suggests diminishing returns above approximately two portions per week, but no study has specifically tested very high intake levels.

Sources & References

1. 1RTHM-00554·Feng, Lei et al. (2019). “The Association between Mushroom Consumption and Mild Cognitive Impairment: A Community-Based Cross-Sectional Study in Singapore..” Journal of Alzheimer's disease : JAD.Study breakdown →PubMed →↩
2. 2RTHM-01865·Cha, Sara et al. (2024). “The Relationship between Mushroom Intake and Cognitive Performance: An Epidemiological Study in the European Investigation of Cancer-Norfolk Cohort (EPIC-Norfolk)..” Nutrients.Study breakdown →PubMed →↩
3. 3RTHM-01849·Aoki, Shoko et al. (2024). “Mushroom intake and risk of incident disabling dementia: the Circulatory Risk in Communities Study (CIRCS)..” The British journal of nutrition.Study breakdown →PubMed →↩
4. 4RTHM-00741·Ba, Djibril M et al. (2022). “Mushroom intake and cognitive performance among US older adults: the National Health and Nutrition Examination Survey, 2011-2014..” The British journal of nutrition.Study breakdown →PubMed →↩
5. 5RTHM-00858·Yan, Yaqiong et al. (2023). “The relationship between mushroom consumption and cognitive performance among middle-aged and older adults: a cross-sectional study..” Food & function.Study breakdown →PubMed →↩
6. 6. Source details for this reference are not yet available.
7. 7RTHM-00952·Surendran, Geyan et al. (2025). “Acute effects of a standardised extract of Hericium erinaceus (Lion's Mane mushroom) on cognition and mood in healthy younger adults: a double-blind randomised placebo-controlled study..” Frontiers in nutrition.Study breakdown →PubMed →↩
8. 8RTHM-00868·Cha, Sara et al. (2024). “A review of the effects of mushrooms on mood and neurocognitive health across the lifespan..” Neuroscience and biobehavioral reviews.Study breakdown →PubMed →↩
9. 9RTHM-00583·Onaolapo, Adejoke Yetunde et al. (2019). “Brain Ageing, Cognition and Diet: A Review of the Emerging Roles of Food-Based Nootropics in Mitigating Age-related Memory Decline..” Current aging science.Study breakdown →PubMed →↩